Main content area

Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells

Gao, Dan, Wang, Lingling, Zhang, Hua, Yan, Xiaojie, Yang, Jie, Zhou, Ruimin, Chang, Xinzhong, Sun, Yanan, Tian, Shanshan, Yao, Zhi, Zhang, Kai, Liu, Zhe, Ma, Zhenyi
TheFEBS journal 2018 v.285 no.22 pp. 4229-4245
adenocarcinoma, biomarkers, humans, lung neoplasms, lungs, messenger RNA, neoplasm cells, non-specific protein-tyrosine kinase, oncogene proteins, protein content, transcription (genetics), transcription factors, tyrosine
Spleen tyrosine kinase (SYK) is a nonreceptor tyrosine kinase with dual properties of an oncoprotein and an oncosuppressor in distinctive cell types. In solid cancers, two isoforms SYK(L) and SYK(S) of SYK were recently identified due to its alternative mRNA splicing. However, the cellular activity and the biological significance of the long isoform of SYK, SYK(L), is still not well defined in human lung cancers. Here, we describe an interaction between SYK(L) and the ubiquitously expressed transcription regulator Yin Yang 1 (YY1) in the nucleus, which suppresses the epithelial‐to‐mesenchymal transition (EMT) by inactivating SNAI2 (coding transcription factor SLUG) transcription. ChIP indicated that endogenous SYK(L) interacts directly with a YY1 binding cis‐regulatory element in the SNAI2 promoter. Importantly, knockdown of YY1 activates SYK(L)‐dependent EMT suppression in human lung cancer H1155 cells. We also found that the protein level of SYK(L) is markedly upregulated in various types of human lung cancers, and its nuclear localization is strongly correlated with clinical benefits of lung adenocarcinomas. Collectively, our data reveal a SYK(L)‐dependent transcriptional regulation of EMT through SLUG as a potential biomarker for lung cancer aggressiveness.